|
Archives: Agenda
Generative AI to improve patient recruitment and retention in oncology trials
| · Provide real-time feasibility insights for better site selection and study design
· Instantly match eligible patients from unstructured EHR data in seconds · Surface future trial candidates based on clinical trajectory (e.g., second-line eligibility while still in first-line treatment) · Predict patient dropout risk and improve retention strategies |
Has RBQM Reached Its Full Potential?
| Risk-Based Quality Management (RBQM) adoption is on the rise — but for many clinical teams, the expected gains in efficiency and cost reduction have yet to materialize.
In this presentation, we’ll examine the disconnect between RBQM’s intended impact and its real-world results. We’ll explore common operational and strategic misalignments and share how TRI is helping clinical trial teams close this gap; transforming RBQM from a theoretical framework into a practical driver of performance and quality.
|
Innovative approaches to driving clinical trial recruitment success
| This presentation highlights the value of a creative, multi-channel recruitment strategy that blends digital outreach, database activation, patient engagement tactics, and community partnerships. As the highest-recruiting site across all our trials, VCTC has successfully delivered participants for large-scale studies, complex rare disease trials, and challenging oncology rescue protocols, demonstrating the power of a flexible, patient-focused recruitment model.
VCTC, your Multi-therapeutic Clinical Research Centre |
Proof-of-concept: bold moves, big wins and lessons learned
Fast, furious or never-ending: case studies on accelerating or unexpectedly inflating Phase IB/II timelines and budgets. A site team perspective
Unlocking the power of primary care for site optimisation
Clinical trials are expensive, and choosing ineffective study sites can lead to wasted time and resources. Through collaboration with primary care, sponsors can benefit from targeted identification of the best locations for recruiting their desired patient population and reduce site burden through effective data sharing. Join us to discover how through collaboration with primary care, electronic health records can enhance recruitment from site selection through to screening.
Navigating the Early Stage Landscape: Market Trends and Insights
- Emerging trends in early stage Evaluating ex-US strategies
- Observations from Novotech’s early-stage sponsors
MHRA: The new outlook of the Clinical Trials Unit
- Activities
- Innovations
- International collaborations
Troubleshooting Challenging Hospital Sites?
- There are many obstacles to running a successful clinical trial – and hospital sites can be one.
- Slow to set up, delays to patient recruitment, or poor data quality?
- TCR-Solutions will share some experience and approaches to troubleshooting these challenges.
- We cannot treat hospital sites like commercial vendors, and we must find a way to work with hospitals to ensure they deliver on time and target.
PANEL DISCUSSION: Exploring the landscape for oncology clinical trials in the UK
- New regulations and guidance around running oncology trials in the UK: what do you need to be aware of?
- Running clinical trials in conjunction with the NHS: how to ensure your trial is a success
- Developments in UK cancer research: what’s new in 2025?
- Assessing the impact of political and economic changes on UK oncology trials
- The role of the cancer drug fund in accelerating oncology clinical trials in the UK